Hero_Image_Fore_Genomics_Nov_15_2024 - Fore Genomics, Inc.

Genetic Screening For 500+ Conditions & 100+ Medications.

Pediatric Health Screening At Home

Order Now

Health Screening Designed For Children

Genetic health screening is vital for early detection of manageable conditions in childhood. Recommended for ages 0-5, it remains available for children up to 18 years old.

Fore Genomics Health Screen with 5-Year Membership - Fore Genomics, Inc.

Why Screen?

Newborns receive basic state-sponsored screening for a handful of conditions, but Fore goes further—providing insights into hundreds of conditions. With Fore’s advanced genetic screening, you gain the knowledge to protect and support your baby’s health from day one. It’s the peace of mind every parent deserves.

Pediatric_Genetic_Health_Screening_Report - Fore Genomics, Inc.

What We Screen For

Risks of neurological and cardiovascular conditions, metabolic disorders, and even pediatric cancers. With this knowledge, you and your child’s doctor can stay ahead—monitoring, preventing, and creating personalized care plans to ensure your little one thrives to their fullest potential

Lifelong Insights

Personalized Medicine is driven by individual health insights based on your genetic profile, resulting in tailored care planning. Engage with our interactive content to learn more about the benefits of the Fore Genomics' Genetic Health Screening. Using genetic health screening builds the foundation for a healthy life.

These tests were developed and performance characteristics were determined by Fore Genomics, Inc. in collaboration with Fore’s service providers. The US Food and Drug Administration (FDA) has not approved or cleared these tests; however, FDA clearance approval is not currently required for clinical use. These tests are used for clinical purposes, and therefore validation was done as required under the requirements of the Clinical Laboratory Improvement Act (CLIA) of 1988. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions. The chance of a false negative or a false-positive result due to laboratory error cannot be completely excluded. These results should not be regarded as investigational or for research.